Search research articles
Contact Us
Filters
Showing results (171-180 of 270) with videos related to
Page
of 27
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
August 26, 2021
Profound Treg perturbations correlate with COVID-19 severity
Silvia Galván-Peña, Juliette Leon, Kaitavjeet Chowdhary, et al.
Pathogens & Immunity
|
May 15, 2024
Safety, Efficacy, and Pharmacokinetics of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies BMS-986414 (C135-LS) and BMS-986413 (C144-LS) Administered Subcutaneously in Non-Hospitalized Persons with COVID-19 in a Phase 2 Trial
Katya C Corado, Kara W Chew, Mark J Giganti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 28, 2019
Antiretroviral Therapy Reduces T-cell Activation and Immune Exhaustion Markers in Human Immunodeficiency Virus Controllers
Jonathan Z Li, Florencia P Segal, Ronald J Bosch, et al.
Biorxiv : the Preprint Server for Biology
|
September 15, 2025
A New Type of Nonsuppressible Viremia Produced by HIV-Infected Macrophage
Matthew J Moeser, Olivia D Council, Nathan Long, et al.
Clinical Immunology (Orlando, Fla.)
|
April 1, 2022
Temporal changes in T cell subsets and expansion of cytotoxic CD4+ T cells in the lungs in severe COVID-19
Naoki Kaneko, Julie Boucau, Hsiao-Hsuan Kuo, et al.
Eclinicalmedicine
|
October 19, 2023
Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trial
Prasanna Jagannathan, Kara W Chew, Mark J Giganti, et al.
Open Forum Infectious Diseases
|
December 5, 2022
Predictors of SARS-CoV-2 RNA From Nasopharyngeal Swabs and Concordance With Other Compartments in Nonhospitalized Adults With Mild to Moderate COVID-19
Carlee Moser, Jonathan Z Li, Joseph J Eron, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 1, 2021
Expansion of Cytotoxic CD4+ T cells in the lungs in severe COVID-19
Naoki Kaneko, Julie Boucau, Hsiao-Hsuan Kuo, et al.
Iscience
|
April 25, 2023
Cell culture systems for isolation of SARS-CoV-2 clinical isolates and generation of recombinant virus
Da-Yuan Chen, Jacquelyn Turcinovic, Shuchen Feng, et al.
The Journal of Infectious Diseases
|
January 20, 2023
Phase 2 Safety and Antiviral Activity of SAB-185, a Novel Polyclonal Antibody Therapy for Nonhospitalized Adults With COVID-19
Babafemi O Taiwo, Kara W Chew, Carlee Moser, et al.
Page
of 27
Search research articles
Search
Showing results (171-180 of 270) with videos related to
Sort By:
Page
of 27
Proceedings of the National Academy of Sciences of the United States of America
|
August 26, 2021
Profound Treg perturbations correlate with COVID-19 severity
Silvia Galván-Peña, Juliette Leon, Kaitavjeet Chowdhary, et al.
Pathogens & Immunity
|
May 15, 2024
Safety, Efficacy, and Pharmacokinetics of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies BMS-986414 (C135-LS) and BMS-986413 (C144-LS) Administered Subcutaneously in Non-Hospitalized Persons with COVID-19 in a Phase 2 Trial
Katya C Corado, Kara W Chew, Mark J Giganti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 28, 2019
Antiretroviral Therapy Reduces T-cell Activation and Immune Exhaustion Markers in Human Immunodeficiency Virus Controllers
Jonathan Z Li, Florencia P Segal, Ronald J Bosch, et al.
Biorxiv : the Preprint Server for Biology
|
September 15, 2025
A New Type of Nonsuppressible Viremia Produced by HIV-Infected Macrophage
Matthew J Moeser, Olivia D Council, Nathan Long, et al.
Clinical Immunology (Orlando, Fla.)
|
April 1, 2022
Temporal changes in T cell subsets and expansion of cytotoxic CD4+ T cells in the lungs in severe COVID-19
Naoki Kaneko, Julie Boucau, Hsiao-Hsuan Kuo, et al.
Eclinicalmedicine
|
October 19, 2023
Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trial
Prasanna Jagannathan, Kara W Chew, Mark J Giganti, et al.
Open Forum Infectious Diseases
|
December 5, 2022
Predictors of SARS-CoV-2 RNA From Nasopharyngeal Swabs and Concordance With Other Compartments in Nonhospitalized Adults With Mild to Moderate COVID-19
Carlee Moser, Jonathan Z Li, Joseph J Eron, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 1, 2021
Expansion of Cytotoxic CD4+ T cells in the lungs in severe COVID-19
Naoki Kaneko, Julie Boucau, Hsiao-Hsuan Kuo, et al.
Iscience
|
April 25, 2023
Cell culture systems for isolation of SARS-CoV-2 clinical isolates and generation of recombinant virus
Da-Yuan Chen, Jacquelyn Turcinovic, Shuchen Feng, et al.
The Journal of Infectious Diseases
|
January 20, 2023
Phase 2 Safety and Antiviral Activity of SAB-185, a Novel Polyclonal Antibody Therapy for Nonhospitalized Adults With COVID-19
Babafemi O Taiwo, Kara W Chew, Carlee Moser, et al.
Page
of 27